Want to see XGN full AI Analyst Report?
Total Valuation
Exagen has a market cap or net worth of $159.64M. The enterprise value is $115.43.
Market Cap$159.64M
Enterprise Value$115.43
Share Statistics
Exagen has 24,225,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,225,340
Owned by Insiders5.05%
Owned by Institutions3.68%
Financial Efficiency
Exagen’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -30.02%.
Return on Equity (ROE)-1.14
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-30.02%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee308.22K
Profits Per Employee-92.37K
Employee Count216
Asset Turnover1.15
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Exagen is ―. Exagen’s PEG ratio is -0.54.
PE Ratio―
PS Ratio1.97
PB Ratio7.51
Price to Fair Value7.51
Price to FCF-9.19
Price to Operating Cash Flow-24.47
PEG Ratio-0.54
Income Statement
In the last 12 months, Exagen had revenue of 66.58M and earned -19.95M in profits. Earnings per share was -0.93.
Revenue66.58M
Gross Profit38.80M
Operating Income-14.07M
Pretax Income-19.90M
Net Income-19.95M
EBITDA-13.46M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -6.50M and capital expenditures -1.09M, giving a free cash flow of -7.59M billion.
Operating Cash Flow-6.50M
Free Cash Flow-7.59M
Free Cash Flow per Share-0.31
Dividends & Yields
Exagen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.43
52-Week Price Change-29.59%
50-Day Moving Average4.85
200-Day Moving Average5.02
Relative Strength Index (RSI)68.25
Average Volume (3m)221.75K
Important Dates
Exagen upcoming earnings date is Nov 16, 2026, After Close (Confirmed).
Last Earnings DateAug 4, 2026
Next Earnings DateNov 16, 2026
Ex-Dividend Date―
Financial Position
Exagen as a current ratio of 3.45, with Debt / Equity ratio of 209.13%
Current Ratio3.45
Quick Ratio3.45
Debt to Market Cap0.17
Net Debt to EBITDA0.48
Interest Coverage Ratio-3.26
Taxes
In the past 12 months, Exagen has paid 51.00K in taxes.
Income Tax51.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Exagen EV to EBITDA ratio is -9.25, with an EV/FCF ratio of -8.73.
EV to Sales1.87
EV to EBITDA-9.25
EV to Free Cash Flow-8.73
EV to Operating Cash Flow-9.14
Balance Sheet
Exagen has $24.59M in cash and marketable securities with $25.55M in debt, giving a net cash position of -$959.00K billion.
Cash & Marketable Securities$24.59M
Total Debt$25.55M
Net Cash-$959.00K
Net Cash Per Share-$0.04
Tangible Book Value Per Share$0.81
Margins
Gross margin is 58.64%, with operating margin of -21.13%, and net profit margin of -29.97%.
Gross Margin58.64%
Operating Margin-21.13%
Pretax Margin-29.89%
Net Profit Margin-29.97%
EBITDA Margin-20.22%
EBIT Margin-23.41%
Analyst Forecast
The average price target for Exagen is $9.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$9.80
Price Target Upside109.40% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast20.83%
EPS Growth Forecast9.70%